These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25226339)

  • 21. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of paroxysmal atrial tachyarrhythmias to volume overload: assessment by implanted transpulmonary impedance monitoring.
    Jhanjee R; Templeton GA; Sattiraju S; Nguyen J; Sakaguchi S; Lu F; Ermis C; Milstein S; Van Heel L; Lurie KG; Benditt DG
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):488-94. PubMed ID: 19843916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
    Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
    Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H
    Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration.
    Maines M; Catanzariti D; Cirrincione C; Valsecchi S; Comisso J; Vergara G
    Europace; 2010 May; 12(5):680-5. PubMed ID: 20047927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure.
    Malfatto G; Della Rosa F; Rella V; Villani A; Branzi G; Blengino S; Giglio A; Facchini M; Parati G
    J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):322-30. PubMed ID: 24699010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient variations of transthoracic impedance as a predictor of heart failure and death in patients with implanted defibrillators.
    Mitrani RD; Sager SJ; Moscucci M; Cogan J; Myerburg RJ
    Int J Cardiol; 2014 Aug; 175(3):473-7. PubMed ID: 25012496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impedance cardiography: a useful and reliable tool in optimization of cardiac resynchronization devices.
    Heinroth KM; Elster M; Nuding S; Schlegel F; Christoph A; Carter J; Buerke M; Werdan K
    Europace; 2007 Sep; 9(9):744-50. PubMed ID: 17496288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
    Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
    Yamokoski LM; Haas GJ; Gans B; Abraham WT
    Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonhemodynamic parameters from implantable devices for heart failure risk stratification.
    Boehmer JP
    Heart Fail Clin; 2015 Apr; 11(2):191-201. PubMed ID: 25834969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy.
    Smith SA; Abraham WT
    Congest Heart Fail; 2011; 17(5):220-6. PubMed ID: 21906246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of thoracic fluid content in heart failure: the role of impedance cardiography.
    Folan L; Funk M
    AACN Adv Crit Care; 2008; 19(1):47-55. PubMed ID: 18418105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathoracic impedance monitoring for early detection of impending heart failure decompensation.
    Abraham WT
    Congest Heart Fail; 2007; 13(2):113-5. PubMed ID: 17392616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
    Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS
    Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial.
    Adamson PB; Gold MR; Bennett T; Bourge RC; Stevenson LW; Trupp R; Stromberg K; Wilkoff BL; Costanzo MR; Luby A; Aranda JM; Heywood JT; Baldwin HA; Aaron M; Smith A; Zile M
    Congest Heart Fail; 2011; 17(5):248-54. PubMed ID: 21906250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: relationship to changes in NT-proBNP.
    Lüthje L; Vollmann D; Drescher T; Schott P; Zenker D; Hasenfuss G; Unterberg C
    Eur J Heart Fail; 2007; 9(6-7):716-22. PubMed ID: 17462948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.